Chief Executive Officer

President and CEO

Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech

Neuren Pharmaceuticals Says Nasdaq-Listed Partner Receives US FDA Approval for Oral Solution; Shares Up 3%

Acadia Pharmaceuticals Inc. Announces FDA Approval of Daybue®? STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement

0.3333333432674408

Area Business Manager

Acadia Pharmaceuticals is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. They are seeking a results-oriented Area Business Manager to promote their FDA-approved treatment for Rett syndrome, develop sales strategies, and build relationships with healthcare providers.

Area Business Manager, Portland, OR

Executive Director, Strategic Planning & Enablement

Acadia Pharmaceuticals is committed to transforming scientific promise into impactful innovations for underserved neurological and rare disease communities. The Executive Director, Strategic Planning & Enablement will lead the strategy for commercial success, overseeing critical functions and driving data-driven planning and cross-functional collaboration to enhance customer engagement and business growth.

Territory Manager | Acadia

Territory Manager | Acadia in united states (1000+)

Area Business Manager, Portland, OR

Executive Director, Strategic Planning & Enablement